Company / Book Value per Share
AXIM BIOTECHNOLOGIES, INC. Book Value per Share History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
-$0.04
FY2023
5-year range
-$0.12 / -$0.035
FY2019-FY2023
Trend
-13.9%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$0.111 to -$0.04 over the past 5 years.
Based on SEC 10-K filings.
-$0.04 in FY2023.
Improved from -$0.111 to -$0.04 over the past 5 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, book value per share decreased 13.9% year-over-year.
- Peak book value per share was recorded in FY2011.
- Lowest book value per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$0.04 | -13.9% |
| FY2022 | -$0.035 | +68.7% |
| FY2018 | -$0.111 | +6.9% |
| FY2017 | -$0.12 | -100.0% |
| FY2016 | -$0.06 | -16.5% |
| FY2015 | -$0.051 | -1705.0% |
| FY2013 | -$0.003 | -1899.1% |
| FY2012 | -$0 | -127.9% |
| FY2011 | $0.001 | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026